Pancreatic cancer trials in Austria

In Austria 16 Also abroad 1095

16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Where
Salzburg
Age
18 years and over
People
670 worldwide
Run by
Revolution Medicines, Inc.
See details and how to joinNCT07621718
Phase 2Not yet taking people in Austria
[⁶⁸Ga]Ga-HKG301(FAP-2286) PET/CT in pancreatic and breast malignancies
Where
Salzburg
Age
18 years and over
People
60
Run by
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
See details and how to join2026-526498-40-00 · EU 2026-526498-40-00
Phase 2/3Taking people
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Where
Graz, Salzburg, Vienna
Age
18 years and over
People
440 worldwide
Run by
Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00
Phase 3Taking people
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Where
Graz, Innsbruck, Linz, Salzburg
Age
18 years and over
People
588 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07522073
Phase 3Not yet taking people in Austria
Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
Where
Innsbruck, Salzburg, Vienna
Age
18 years and over
People
233 worldwide
Run by
Revolution Medicines Inc.
See details and how to join2025-524969-24-00 · EU 2025-524969-24-00
Phase 2/3Not yet taking people in Austria
A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma
Where
Linz, Salzburg, Vienna
Age
18 years and over
People
194 worldwide
Run by
AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-522563-15-00 · EU 2025-522563-15-00
Phase 3Taking people
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Where
Graz, Linz, Steyr, Vienna
Age
18 years and over
People
900 worldwide
Run by
Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00
Phase 1/2Taking people
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC)
Where
Salzburg, Vienna
Age
18 years and over
People
26 worldwide
Run by
Merck Healthcare KGaA
See details and how to join2024-517819-74-00 · EU 2024-517819-74-00
Phase 3Taking people
Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
Where
Linz, Salzburg, Vienna, Wels, Wiener Neustadt
Age
18 years and over
People
281 worldwide
Run by
Revolution Medicines Inc.
See details and how to join2025-524928-21-00 · EU 2025-524928-21-00
Phase 3Taking people
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
Where
Innsbruck, Linz, Salzburg, Vienna
Age
18 years and over
People
239 worldwide
Run by
Incyte Corp.
See details and how to join2025-525009-18-00 · EU 2025-525009-18-00
No phaseTaking people
Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
Where
Amstetten, Feldkirch, Graz, Innsbruck, Klagenfurt, Linz, Salzburg, Sankt Pölten, Vienna, Zams
Age
18 years and over
People
1,500
Run by
Medical University of Graz
See details and how to joinNCT05526443
No phaseNot yet taking people in Austria
Digitally Supported Prehabilitation Before Major Visceral Cancer Surgery
Where
Saint Veit Im Pongau, Salzburg
Age
18 years and over
People
30
Run by
Ludwig Boltzmann Institute for Digital Health and Prevention
See details and how to joinNCT07658313
No phaseTaking people
Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer
Where
Wiener Neustadt
Age
18 years and over
People
10
Run by
EBG MedAustron GmbH
See details and how to joinNCT04894643
No phaseTaking people
Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)
Where
Wiener Neustadt
Age
18 years and over
People
30
Run by
EBG MedAustron GmbH
See details and how to joinNCT05191940
Phase 2/3Taking people
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Where
Feldkirch, Klagenfurt Am Woerthersee, Linz, Salzburg, Steyr, St. Pölten, Vienna, Wels, Wien
Age
18 years and over
People
600 worldwide
Run by
Panbela Therapeutics, Inc.
See details and how to joinNCT05254171 · EU 2024-514714-12-00
No phaseTaking people
The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer
Where
Vienna
Age
18 years to 99 years
People
1,500
Run by
Medical University of Vienna
See details and how to joinNCT05752812